Phase I trial of intravesical Bacillus Calmette–Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette–Guérin treatment
Shaheen Alanee, Sherjeel Sana, Ahmed El‐Zawahry, James O. Peabody, Tiffany Pearce, Nicole Adams, Mustafa Deebajah, Jane Crabtree, Kristin Delfino, Kevin T. McVary, Kathy Robinson, Krishna Rao
Topics & Concepts
MedicinePembrolizumabBladder cancerBacillus (shape)NephrologyInternal medicineUrologyCancerGastroenterologyOncologyImmunotherapyPathologyMicrobiologyBiologyBladder and Urothelial Cancer TreatmentsImmune responses and vaccinationsUrinary Tract Infections Management